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Abstract: Sofrito is a Mediterranean tomato-based sauce that typically also contains olive oil, onion,
and garlic. The preparation of sofrito modifies the bioactive compounds (carotenoids and polyphenols)
in the ingredients to more bioavailable forms, promoting cis-lycopene formation and polyphenol
bioaccessibility. To evaluate the health benefits of this cooking technique, the effect of consuming an
acute dose of sofrito on the inflammatory status was studied. In a clinical trial, 22 healthy male subjects
consumed a single dose of sofrito (240 g/70 kg) after three days without ingesting any tomato products
and following a low-antioxidant diet the day before the intervention. Plasma carotenoids and total
polyphenol excretion (TPE) were evaluated, as well as the inflammatory biomarkers C-reactive protein
(CRP), interleukin-6 (IL-6), interleukin 1β (IL-1β) and tumor necrosis factor-α (TNF-α). After the
sofrito intake, a significant decrease in CRP (p = 0.010) and TNF-α (p = 0.011) was observed, but only
TNF-α was inversely correlated with an increase in TPE and plasma β-carotene (not the major
carotenoid, lycopene). The positive health effects of this tomato-based product may be attributed not
only to lycopene, but to the bioactive compounds of all the ingredients.
Keywords: carotenoids; polyphenols; TNF-α; CRP; lycopene; β-carotene; bioavailability; Mediterranean;
onion; extra virgin olive oil
1. Introduction
Sofrito is a sauce commonly used to prepare dishes in Mediterranean cuisine. It is based on tomato
but also contains other ingredients, typically olive oil, onion, and garlic. The regular consumption of
this sauce is included in a validated 14-item questionnaire to evaluate adherence to the Mediterranean
diet [1,2].
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Numerous studies have provided evidence for the protective role of tomato-based products
and their bioactive compounds against the development of cardiovascular diseases and cancer [3,4],
which is partly attributed to positive effects on inflammatory biomarkers [5–7].
The polyphenol and carotenoid profile of sofrito varies according to its composition [8], but as
tomato is the principle ingredient, the major carotenoids are lycopene andβ-carotene [8]. Carotenoids in
food are mainly all-trans isomers, whereas cis-isomers predominate in the human organism [9]. Factors
such as cooking practices and the food matrix promote the isomerization of carotenoids and their
bioavailability [9–11], the latter being increased by the presence of lipids [12–14]. Our research group
recently reported an enhanced formation of cis-lycopene in sofrito associated with the concentration
of onion and the cooking time [15]. The total polyphenol content of tomatoes could be increased
by processing [16], and the bioaccessibility of tomato polyphenols is enhanced by processing and
oil addition [17–19]. Thus, due to its phytochemical content, sofrito seems to be a health-promoting
component of the Mediterranean diet.
Although the impact of tomato products on health has been mainly associated with
lycopene [4,20,21], the other bioactive compounds present in sofrito could also be implicated [22,23].
Previous studies have reported inhibitory effects of dietary phytochemicals on nuclear factor
kappa-light-chain-enhancer of activated B cells (NF-κB) activation in macrophages, resulting in
a decrease in pro-inflammatory cytokines and chemokines like interleukin (IL)-6, IL-1β, and tumor
necrosis factor (TNF-α) [24,25]. As these molecules stimulate the production of C-reactive protein
(CRP) in the liver, which activates NF-κB [26], their reduction could diminish the CRP level. In the
current work, it was hypothesized that phytochemical compounds present in sofrito could improve the
baseline inflammation level. Thus, the aim of this study was to evaluate the effect of a single dose of
240 g/70 kg of sofrito on the regulation of inflammatory biomarkers in healthy humans and to identify
the biomarkers responsible for these changes.
2. Materials and Methods
2.1. Sofrito Samples
Sofrito samples were supplied by Gallina Blanca (GB Foods, Spain) and consisted of a mix of
tomato (50%), onion (37%), extra virgin olive oil (12%), and salt. Every sample was packed in a glass
jar that contained 350 g of the sofrito. The nutritional and phytochemical composition of sofrito are
provided in Tables S1 and S2.
2.2. Participants
The study was carried out with twenty-two healthy male volunteers aged between 18 and 32.
All participants provided written informed consent in advance. Only men were enrolled in the trial to
avoid effects related to hormonal fluctuations during the menstrual cycle [27–29]. Exclusion criteria
were chronic illness or homeostatic disorder, history of cardiovascular diseases, hypertension or
dyslipidemia, toxic habits (such as use of tobacco, alcohol, and drugs), and tomato or onion allergy
or intolerance.
2.3. Intervention
In this open, uncontrolled and acute nutritional study, all participants ingested a single portion of
sofrito (240 g/70 kg body weight) in a state of fasting. Before the intervention, volunteers avoided eating
tomatoes and their by-products for three days. One day before the intervention, they also followed
a low antioxidant diet, which was continued until the last blood sample was drawn (24 hours after
consumption of sofrito). The details of the diet are presented in Supplementary Material Table S3.
The study was run in the Department of Nutrition, Food Sciences and Gastronomy of the
Food and Nutrition Torribera Campus, University of Barcelona (Spain), according to the principles
of the Declaration of Helsinki. The protocol was approved by the Ethics Committee of Clinical
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Investigation of the University of Barcelona (Barcelona, Spain). The clinical trial was registered
and given the International Standard Randomized Controlled Trial Number (http://www.isrctn.com/)
of ISRCTN17867378.
2.4. Dietary and Physical Activity Assessments
In order to complete the dietary register, subjects were asked to fill out a three-day food recall
on the day of the intervention. These were analyzed using PCN Pro software (Programa de Càlcul
Nutricional Professional, Santa Coloma de Gramenet, Barcelona). Physical activity was measured by
the validated Spanish version of the Minnesota Leisure-Time Physical Activity Questionnaire [30].
2.5. Extraction of Biological Samples
Fasting blood and urine samples were drawn before sofrito consumption (baseline extraction)
and up to 24 hours afterwards (Figure 1). Blood samples were collected via venipuncture in the arm
through EDTA tubes, and plasma was separated after centrifugation at 1902 g for 15 min at 4 ◦C.
Plasma and urine were aliquoted and stored at −80 ◦C until the day of analysis.
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The diastolic and systolic blood pressure (DBP and SBP, respectively) and heart rate (HR) were 
measured in triplicate by a blood pressure monitor before and after the intake of a single dose of 
sofrito. 
Biochemistry parameters in plasma were evaluated in an external laboratory (mdb.lab Durán 
Bellido, Barcelona). High density lipoprotein (HDL), low density lipoprotein (LDL), total cholesterol 
and triglycerides were analyzed by an enzymatic method. Urea and uric acid were analyzed by 
enzymatic and enzymatic/chromogen methods, respectively. Creatinine was determined by reaction 
kinetics of the Jaffe method (as modified by Larsen). Total proteins and albumin were measured by 
the endpoint biuret reaction and bromocresol green methods, respectively. 
2.7. Analysis of Total Polyphenol Excretion in Urine 
After a solid phase extraction (SPE) using a 96-well plate cartridge (Oasis MAX), total 
polyphenol excretion (TPE) analysis was performed in 2 mL of diluted (1:1) and acidified urine 
samples by the Folin–Ciocalteu method [31]. The spectrophotometry analysis was carried out using 
a Thermo Scientific Multiskan® Spectrum (Thermo Fisher Scientific, Vantaa, Finland, ref. 15019000) 
at a wavelength of 765 nm. The results are expressed as mg of gallic acid equivalent/L of urine 
(GAE/L). A cumulative urinary excretion curve for total polyphenols was calculated from 0 to 24 h.  
2.8. Quantitative Analysis of Carotenoids in Plasma 
Carotenoids were extracted by liquid–liquid extraction from plasma samples collected at 0 h and 
24 h [32]. Chromatographic analysis of carotenoids was performed by HPLC-UV-DAD, using an HP 
Figure 1. Timeline of sample collection before a ft r i t f sofrito. On the left, baseline extraction
of blood and urine. On the right, sample dra n after sofrito consu ption: collection of blood at 24 h
and cumulative urine at 0–3, 3–5, 5–12, and 12–24 h.
2.6. Clinical nd Biochemical Evaluations
The diastolic and systolic blo d press r P, r s ectively) and heart rate (HR) w re
measured in triplicate by a blood pressure monitor before and after the intake of a single dose f sofrito.
Bi chemistry parameters in plasma were evaluated in an external laboratory (mdb.lab Durán
Bellido, Barcelona). High density lipoprotein (HDL), low density lipoprotein (LDL), total cholesterol
and triglycerides were analyzed by an enzymatic method. Urea and uric acid were analyzed by
enzymatic and enzymatic/chromogen methods, respectively. Creatinine was determined by reaction
kinetics of the Jaffe method (as modified by Larsen). Total proteins and albumin were measured by the
endpoint biuret reaction and bromocresol green methods, respectively.
2.7. Analysis of Total Polyphenol Excretion in Urine
After a solid phase extraction (SPE) using a 96-well plate cartridge (Oasis MAX), total polyphenol
excretion (TPE) analysis was performed in 2 mL of diluted (1:1) and acidified urine samples by the
Folin–Ciocalteu method [31]. The spectrophotometry analysis was carried out using a Thermo Scientific
Multiskan®Spectrum (Thermo Fisher Scientific, Vantaa, Finland, ref. 15019000) at a wavelength of
765 nm. The results are expressed as mg of gallic acid equivalent/L of urine (GAE/L). A cumulative
urinary excretion curve for total polyphenols was calculated from 0 to 24 h.
2.8. Quantitative Analysis of Carotenoids in Plasma
Carotenoids were extracted by liquid–liquid extraction from plasma samples collected at 0 h
and 24 h [32]. Chromatographic analysis of carotenoids was performed by HPLC-UV-DAD, using
an HP 1100 HPLC system (Hewlett-105 Packard, Waldbronn, DE) containing a quaternary pump
coupled to a DAD G1315B. The separation was carried out with Milli-Q water, methanol (MeOH) and
methyl-tert-butyl ether (MTBE) (Panreac Quimica S.A., Barcelona, Spain), according to a procedure
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previously validated in our group [32]. A Waters RP column YMC Carotenoid S-5 µm (250 mm × 4.6
mm) and a precolumn YMC Guard Cartridge Carotenoid S-5 µm (20 mm × 4.0 mαm) were used.
Zeaxanthin (Extrasynthese, Genay, France), lutein, cryptoxanthin, α-carotene, β-carotene 9-
and 13-cis-β-carotene (Sigma-Aldrich, St. Louis, MO, USA), lycopene (Fluka, Bucks, Switzerland),
and 5-cis-lycopene (CaroteNature GmbH, Münsingen, Switzerland) were used as standards. These
were pooled and prepared in synthetic human plasma (Sigma-Aldrich, St. Louis, MO, USA).
The sensitivity of each analyte was 0.703 µmol/L (lutein), 0.352 µmol/L (zeaxanthin), 0.362 µmol/L
(cryptoxanthin), 0.480 µmol/L (trans-β-apo-8’-carotenal), 0.745 µmol/L (13-cis-β-carotene), 0.373 µmol/L
(9-cis-β-carotene and trans-β-carotene), and 0.186 µmol/L (trans and cis-lycopenes) [32].
2.9. Determination of Plasmatic Inflammatory Biomarkers
Plasmatic C-reactive protein (CRP) was measured by an immunoturbidimetric method from
external services (mdb.lab Durán Bellido) at baseline and 24 h after consumption of sofrito.
The concentrations of interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α) and interleukin 1β
(IL-1β) were assayed in plasma using the Immunoassay Kit (R&D Systems Inc., Minneapolis, USA,
refs. HS600B, HSTA00E, HSLB00D). The sensitivity of each analyte was 0.110 pg/mL, 0.049 pg/mL,
and 0.063 pg/mL, respectively. Plasma samples were assayed in duplicate.
2.10. Statistical Analysis
Normality of distribution was assessed by a Shapiro–Wilk test. In order to compare baseline and
post-intervention values, a linear regression analysis was used for the normal variables (SDP and DBP,
HR, HDL, uric acid, albumin and TNF-α). Non-normal variables were assessed by a non-parametric
Wilcoxon signed-rank test. The log-transformed TPE variable was analyzed by a Bonferroni post hoc
test to compare the excretion of total polyphenols at the different time points. Statistical analyses were
performed with SPSS Version 23.0 for Windows (SPSS Inc., Chicago, IL, USA).
The correlation analysis was carried out using a correlation matrix that considers repeated
measures [33] with software R, version 3.4.2. The Pearson coefficient (r) was calculated. Significant
correlations (p < 0.05) are shown in the results.
3. Results
3.1. Characteristics of Participants
Table 1 provides anthropometric measurements of the participants, as well as the degree of
adherence to the Mediterranean diet, level of physical activity and nutrient intake at the study baseline.
Table 1. Anthropometric parameters of subjects, physical activity in leisure time according to the
Minnesota questionnaire, and the mean nutrient intake from a 3-day food recall.
Characteristics
Age (years) 23.64 ± 0.86
BMI (kg/m2) 24.91 ± 0.79
WHR 0.84 ± 0.01
MedDiet adherence (score) 1 8.5 ± 0.4
Physical activity in leisure time (METs/d) 746 ± 71
Energy (kcal/day) 2393 ± 129
Total fats (g/day) 106 ± 9
Saturated fats (g/day) 32 ± 3
Monounsaturated (g/day) 47 ± 4
Polyunsaturated (g/day) 19 ± 2
Cholesterol (mg/day) 301 ± 30
Carbohydrate (g/day) 256 ± 15
Protein (g/day) 100 ± 6
Fiber (g/day) 30 ± 2
Data are mean ± standard error of the mean (SEM). BMI: body mass index, WHR: waist–hip ratio, MedDiet:
Mediterranean diet, METs/d: metabolic equivalent of task per day. 1 The score categories of adherence to the
MedDiet are high (≥10), moderate (6–9), and low (≤5).
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3.2. Clinical Measures
Clinical measures are shown in Table 2. Systolic blood pressure did not change after consumption
of sofrito compared to baseline, whereas diastolic blood pressure decreased (p = 0.006). The total
cholesterol was lower after the intervention, mainly due to a reduction of HDL (p = 0.005 and
0.015), although significant changes in LDL and triglycerides were not observed. Urea, total proteins,
and albumin decreased significantly (p = 0.023, 0.011, and 0.015).
Table 2. Clinical parameters of all participants in the study.
Measures Baseline ACS P
DBP (mmHg) # 76 ± 2 71 ± 2 0.006 *
SBP (mmHg) # 123 ± 2 124 ± 2 0.550
HR (bpm) # 66 ± 21 62 ± 2 0.061
Total cholesterol (mmol/L) # 3.83 ± 0.12 3.71 ± 0.12 0.005 *
HDL (mmol/L) 1.37 ± 0.06 1.32 ± 0.06 0.015 *
LDL (mmol/L) # 2.04 ± 0.11 1.98 ± 0.11 0.130
Triglycerides (mmol/L) # 0.94 ± 0.08 0.89 ± 0.06 0.531
Urea (mmol/L) 5.56 ± 0.30 5.08 ± 0.28 0.023 *
Creatinine (µmol/L) 76 ± 2 74 ± 1 0.157
Uric acid (µmol/L) # 319 ± 11 319 ± 10 1.000
Total proteins (g/L) # 73 ± 0.6 71± 0.6 0.011 *
Albumin (g/L) # 47 ± 0.5 46 ± 0.5 0.015 *
Data are mean ± SEM. ACS: after consumption of sofrito (at 24 h). DBP: diastolic blood pressure. SBP: systolic blood
pressure. HR: heart rate. * p-value < 0.05. # Data analyzed by linear regression. The remaining data were analyzed
by the Wilcoxon test.
3.3. Phenolic Excretion in Urine
As a biomarker of polyphenol intake from the sofrito, the urinary excretion of total polyphenols
from baseline until 24 hours after consumption was analyzed (Figure 2A). The TPE increased from
baseline to 5 h after intake, and even more so from 12 to 24 h (p = 0.001), as illustrated by the cumulative
curve in Figure 2B.Nutrients 2019, 11, x FOR PEER REVIEW 6 of 13 
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refer to statistically significant differences as follows. a: p = 0.001; b: p = 0.003; c: p <0.001, and d: p = 
0.048. Data are expressed as mean + SEM. 
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Levels of carotenoids in plasma were evaluated before and after sofrito consumption (Table 3). 
All target carotenoids increased after the intervention, the predominant ones being 5-cis-lycopene, β-
carotene and trans-lycopene. Total lycopene increased from 43% to 59% of total carotenoids. 
Xanthophylls, lutein, and cryptoxanthin increased significantly (p = 0.001 and 0.012) and zeaxanthin 
was detected in plasma after sofrito consumption but not at baseline. In all participants, a high 
concentration of carotenes was found at 24 h of sofrito intake. Notably, the changes in trans-β-carotene 
were highly significant (p <0.001), and the 9-cis-isoform and 13-cis-β-carotene were observed after the 
intervention but not at baseline. Other carotenes that increased were trans-lycopene (p <0.001) and 
13- and 5-cis-lycopene (p = 0.005 and <0.001). The concentration of 9-cis-lycopene was detected after
the consumption of sofrito but not at baseline. In addition, the total cis-lycopene was significantly
higher (p <0.001), as was the total lycopene (p <0.001). In summary, the increase in carotenoid
concentration was statistically significant after the consumption of sofrito, total carotenoids being
three-fold higher compared to the baseline level (p <0.001).
Table 3. Concentration of carotenoids in plasma at baseline and 24 h after consumption of sofrito. 
Analyte Baseline ACS p 
Lutein (µmol/L) 1.12 ± 0.02 1.69 ± 0.27 0.001* 
Zeaxanthin (µmol/L) n.d. 0.65 ± 0.19 - 
Cryptoxanthin (µmol/L) 1.08 ± 0.12 1.34 ± 0.15 0.012* 
trans-β-carotene (µmol/L) 3.12 ± 0.58 6.64 ± 0.88 <0.001* 
13-cis-β-carotene (µmol/L) n.d. 0.75 ± 0.15 - 
9-cis-β-carotene (µmol/L) n.d. 0.95 ± 0.22 - 
trans-lycopene (µmol/L) 2.15 ± 0.30 6.33 ± 1.53 <0.001* 
5-cis-lycopene (µmol/L) 1.87 ± 0.28 7.93 ± 2.73 <0.001* 
13-cis-lycopene (µmol/L) 0.21 ± 0.11 2.08 ± 0.78 0.005* 
9-cis-lycopene (µmol/L) n.d. 0.90 ± 0.58 - 
Total cis-β-carotene (µmol/L) n.d. 1.92 ± 0.33 - 
Total β-carotene 3.45 ± 0.67 8.56 ± 1.13 <0.001* 
Figure 2. (A) Concentration of total polyphenols in the cumulative urine after consumption of a single
serving of sofrito. (B) Cumulative urinary excretion curve of total polyphenols. Urinary total polyphenol
excretion is shown: 0–3 (3 h), 0–5 (5 h), 0–12 (12 h), and 0–24 (24 h). The same letters (a–d) refer to
statistically significant differences as follows. a: p = 0.001; b: p = 0.003; c: p <0.001, and d: p = 0.048.
Data are expressed as mean + SEM.
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3.4. Quantification of Carotenoids in Plasma
Levels of carotenoids in plasma were evaluated before and after sofrito consumption (Table 3).
All target carotenoids increased after the intervention, the predominant ones being 5-cis-lycopene,
β-carotene and trans-lycopene. Total lycopene increased from 43% to 59% of total carotenoids.
Xanthophylls, lutein, and cryptoxanthin increased significantly (p = 0.001 and 0.012) and zeaxanthin
was detected in plasma after sofrito consumption but not at baseline. In all participants, a high
concentration of carotenes was found at 24 h of sofrito intake. Notably, the changes in trans-β-carotene
were highly significant (p < 0.001), and the 9-cis-isoform and 13-cis-β-carotene were observed after the
intervention but not at baseline. Other carotenes that increased were trans-lycopene (p < 0.001) and 13-
and 5-cis-lycopene (p = 0.005 and <0.001). The concentration of 9-cis-lycopene was detected after the
consumption of sofrito but not at baseline. In addition, the total cis-lycopene was significantly higher
(p < 0.001), as was the total lycopene (p < 0.001). In summary, the increase in carotenoid concentration
was statistically significant after the consumption of sofrito, total carotenoids being three-fold higher
compared to the baseline level (p < 0.001).
Table 3. Concentration of carotenoids in plasma at baseline and 24 h after consumption of sofrito.
Analyte Baseline ACS p
Lutein (µmol/L) 1.12 ± 0.02 1.69 ± 0.27 0.001 *
Zeaxanthin (µmol/L) n.d. 0.65 ± 0.19 -
Cryptoxanthin (µmol/L) 1.08 ± 0.12 1.34 ± 0.15 0.012 *
trans-β-carotene (µmol/L) 3.12 ± 0.58 6.64 ± 0.88 <0.001 *
13-cis-β-carotene (µmol/L) n.d. 0.75 ± 0.15 -
9-cis-β-carotene (µmol/L) n.d. 0.95 ± 0.22 -
trans-lycopene (µmol/L) 2.15 ± 0.30 6.33 ± 1.53 <0.001 *
5-cis-lycopene (µmol/L) 1.87 ± 0.28 7.93 ± 2.73 <0.001 *
13-cis-lycopene (µmol/L) 0.21 ± 0.11 2.08 ± 0.78 0.005 *
9-cis-lycopene (µmol/L) n.d. 0.90 ± 0.58 -
Total cis-β-carotene (µmol/L) n.d. 1.92 ± 0.33 -
Total β-carotene 3.45 ± 0.67 8.56 ± 1.13 <0.001 *
Total cis-lycopene isomers (µmol/L) 2.09 ± 0.32 10.91 ± 4.00 <0.001 *
Total lycopene (µmol/L) 4.24 ± 0.59 17.23 ± 5.50 <0.001 *
Total carotenoids (µmol/L) 9.97 ± 0.96 29.25 ± 6.45 <0.001 *
Data are mean ± SEM. ACS: after consumption of sofrito (at 24 h). * Significant differences when p-value < 0.05.
Data were analyzed by the Wilcoxon test. n.d.: not detectable.
3.5. Inflammatory Biomarkers
After the consumption of sofrito, all the inflammatory biomarkers studied decreased compared to
the baseline. However, the changes were only significant for CRP (p = 0.010) and TNF-α (p = 0.011)
(Figure 3A and 3C), but not IL-6 (Figure 3B). In no case was IL-1β detected (data not shown).
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In addition, an inverse correlation was observed between the concentration of β-carotene in
plasma and TNF-α, but not CRP and IL-6 (r = −0.41, p = 0.05) (Figure 5).
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4. Discussion
In this clinical trial, healthy individuals showed higher carotenoid levels in plasma 24 h after the
consumption of sofrito. Arranz et al. reported higher plasma concen rations of cis-isomers of lycopene
but not of other cis-caro enoids aft r the ingestion of tomato sau e withou ion and garlic [12]. In th
current s udy, both cis- and trans-isoforms of β-carotene and lycopene ncreased after sofrito intake.
Not detect d at baseline, 13 and 9-cis-isomer f β-carotene and 9-cis-lycopene were quantified afte
the intervention.
TPE levels had increased significantly at 12-24 h after sofrito intake compared to the baseline.
In a previous study by our group, also in healthy volunteers, changes in polyphenol excretion were
noted earlier, at 6-12 h after the consumption of a tomato-based product without onion [19]. Thus,
the presence of polyphenols from onion in the sofrito could have a delaying effect on the urinary
TPE [34].
It was initially hypothesized that phytochemicals in sofrito could affect the regulation of systemic
pro-inflammatory markers through the inhibition of NF-κB, triggering a decrease in cytokines,
chemokines and CRP [24–26]. After the sofrito intake, a significant reduction of CRP and TNF-α
biomarkers (p = 0.010 and 0.011) in plasma was observed, but not of IL-6. The decrease in TNF-α was
inversely correlated with TPE and the level of β-carotene.
In a previous study, both CRP and TNF-α decreased significantly in healthy volunteers after
the consumption of tomato juice twice daily for 2 weeks [5]. In obese and overweight participants
who consumed tomato juice for 20 days, the concentration of TNF-α decreased, and in obese subjects
the level of IL-6 was significantly reduced, but no changes in CRP were observed in either case [35].
In contrast, in a parallel study, a significant decrease in CRP was observed in women (but not men)
suffering from heart failure who consumed tomato juice for a month [36]. Gender-related differences
in CRP have been previously described [37,38]. In a crossover trial, tomato paste attenuated the
increase in IL-6 after a high-fat meal in healthy volunteers [6]. However, Valderas-Martínez et al.
reported that healthy subjects showed a significant reduction in IL-6 only after consuming tomato
sauce containing olive oil (a single dose), but not raw tomato or tomato sauce without olive oil [7].
A study in schoolchildren found that plasma β-carotene levels were inversely related to IL-6 and CRP,
particularly the former, but not to TNF-α [39]. In patients with cardiovascular diseases, β-carotene was
significantly correlated with IL-6 [40] and CRP [22]. In contrast, other authors did not find changes in
these inflammatory biomarkers after interventions with tomato products or a high-tomato diet [41–46].
In summary, an acute effect on inflammatory biomarkers was observed at 24 h after the
administration of a single dose of 240 g/70 kg of sofrito. Improvements in inflammatory biomarkers
Nutrients 2019, 11, 851 9 of 12
after the ingestion of tomato products have been attributed mainly to lycopene. However, the results
reported here indicate that when the product contains other ingredients, such as onion and virgin olive
oil, different bioactive compounds such as polyphenols and carotenoids such as β-carotene may be
responsible for the anti-inflammatory effects.
A strong point of this work is that relatively few acute studies have been carried out on the
impact of diet on inflammatory biomarkers in healthy humans. The significant reduction in TNF-α
and CRP levels after the ingestion of a single dose of tomato-based sofrito, rich in bioactive compounds,
suggests this Mediterranean sauce may contribute positively to the regulation of the inflammatory
status, even in individuals with optimal health.
The main limitation of the study is the lack of controls. Nevertheless, the analyses were carried
out 24 h after the intervention in the same conditions to avoid changes due to circadian rhythms,
and the volunteers continued a low antioxidant diet after the consumption of sofrito.
5. Conclusions
The addition of sofrito to dishes and cuisine could contribute to the maintenance of health.
An improvement in inflammatory biomarkers, particularly CRP and TNF-α, was observed after a
single dose of sofrito, even though the subjects were healthy. Beneficial effects of sofrito intake could
be partly attributed to the presence of bioactive compounds (polyphenols and carotenoids) from the
ingredients. Although the health-protecting role of lycopene from tomato has been extensively studied,
other carotenoids such as β-carotene (also found in large amounts in tomato by-products) seem to
modulate the regulation of the inflammatory status.
Supplementary Materials: The following are available online at http://www.mdpi.com/2072-6643/11/4/851/s1.
Table S1: Nutritional value of sofrito; Table S2: Comparison of phytochemical composition of tomato and sofrito
samples; Table S3: Recommendations to follow a low antioxidant diet.
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